News | January 02, 2008

Stent Graft Method Offers Safer Surgical Repair for Some Aneurysms

January 3, 2008 - A modular stent graft that inserts multiple, caudally-directed branches to the visceral arteries to repair a thoracoabdominal aortic aneurysm (TAAA) can offer a safer surgical method for patients in need of this surgery, according to a recent study in the January 2008 issue of the Journal of Vascular Surgery.

University of California at San Francisco (UCSF) researchers (who have studied stent grafts for TAAA since 2000), maintain that this less invasive approach eliminates aneurysm flow, while preserving visceral perfusion and avoiding the main physiologic stresses. In the endovascular approach there is no need to open the abdomen, expose the aneurysm, or clamp the aorta, which should translate into less mortality, morbidity, pain and debility.

"Our team has used various stent graft components connected in a number of ways," said Timothy A. M. Chuter, M.D., division of vascular surgery at UCSF, and research team leader. "Our current technique employs a springy (self-expanding) stent-graft that curves downwards and outwards from the main trunk to mimic the branching pattern of a normal thoracoabdominal aorta."

The current study between January 2006 and May 2007, showed that 22 patients with an average age of 76 years (all unfit for open repair and nine had undergone prior aortic surgery), were successfully treated with self-expanding covered stents connecting the caudally-directed cuffs of an aortic stent graft with the visceral branches of an aortic aneurysm (81 branches in all). These customized aortic stent grafts were inserted through the femoral (16) or iliac (6) arteries, where covered stents were inserted through the brachial arteries. Two patients died perioperatively: one from guidewire injury to a renal arterial branch and the other from a medication error.

Routine follow-up included contrast enhanced CT scans at one week, one month, six months and one year. One branch (renal artery) occluded at one month. The other 80 branches remain patent. There were no signs of stent graft migration, component separation or fracture.

Serious or potentially serious complications occurred in 9 of 22 patients, but there was no paraplegia, renal failure, stroke or myocardial infarction among the 20 surviving patients. Complications included one patient who had a localized intimal disruption, who underwent successful reintervention. Another patient had aortic dissection (early), type I endoleak (early) and stenosis of the superior mesenteric artery (late). Also, one patient has a type II endoleak.

Dr. Chuter added that the rate of serious complications in this recent series was relatively low, and endovascular repair is feasible in most TAAAs. The best candidates for endovascular repair are patients with an extensive TAAA (type II or type III), previous aortic surgery and an otherwise normal life expectancy."

For more information: www.jvascsurg.org


Related Content

News | Stent Grafts

April 26, 2023 — Medtronic today announced its Endurant abdominal aortic aneurysm (AAA) stent graft system continues to ...

Home April 26, 2023
Home
News | Stent Grafts

January 12, 2023 — Medtronic announced the first patient enrollment in the ADVANCE Trial, a head-to-head randomized ...

Home January 12, 2023
Home
News | Stent Grafts
May 4, 2022 – Seeking to bolster its development of a biocompatible graft that promises to reshape the future of cardiac ...
Home May 04, 2022
Home
News | Stent Grafts

October 9, 2019 — Medtronic plc announced it has received Breakthrough Device designation from the U.S. Food and Drug ...

Home October 09, 2019
Home
News | Stent Grafts

October 8, 2019 — PQ Bypass Inc. announced it has received full approval of its investigational device exemption (IDE) ...

Home October 08, 2019
Home
News | Stent Grafts

July 10, 2019 — W. L. Gore & Associates Inc. (Gore) announced the first U.S. implant of the Gore Tag Conformable ...

Home July 10, 2019
Home
Technology | Stent Grafts

May 15, 2019 — W. L. Gore & Associates Inc. (Gore) announced the U.S. Food and Drug Administration (FDA) has granted ...

Home May 15, 2019
Home
News | Stent Grafts

February 14, 2019 — Abdominal aortic stent grafts will remain the largest segment in the global aortic stent graft ...

Home February 14, 2019
Home
Technology | Stent Grafts

February 7, 2019 — Medtronic plc recently received U.S. Food and Drug Administration (FDA) approval for the Valiant ...

Home February 07, 2019
Home
News | Stent Grafts

January 7, 2019 — Endologix Inc. announced that in order to ensure optimal outcomes for patients, unrestricted sales and ...

Home January 07, 2019
Home
Subscribe Now